Michael Logerfo Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Logerfo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Logerfo. Michael Logerfo is Chief Legal Officer in Sagent Pharmaceuticals, Inc. ($SGNT) and President in Sagent Pharmaceuticals, Inc. ($SGNT) and President, CLO in Sagent Pharmaceuticals, Inc. ($SGNT) and President, CLO and Secretary in Sagent Pharmaceuticals, Inc. ($SGNT).
Latest Insider Trading Transactions of Michael Logerfo
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 14.58 | 402 | 5,861 | 53,292 | 53.7 K to 53.3 K (-0.75 %) |
Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 14.61 | 486 | 7,100 | 53,694 | 54.2 K to 53.7 K (-0.90 %) |
Feb 23 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 14.61 | 744 | 10,870 | 54,180 | 54.9 K to 54.2 K (-1.35 %) |
Feb 22 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO | Payment of Exercise | F | 0.00 | 634 | 0 | 54,924 | 55.6 K to 54.9 K (-1.14 %) |
Jan 05 2016 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President, CLO and ... | Payment of Exercise | F | 15.85 | 924 | 14,645 | 55,558 | 56.5 K to 55.6 K (-1.64 %) |
May 13 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President | Option Exercise | M | 4.31 | 2,759 | 11,891 | 10,000 | |
May 13 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | President | Buy | M | 4.31 | 2,759 | 11,891 | 56,482 | 53.7 K to 56.5 K (+5.14 %) |
Apr 01 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 5,480 | 0 | 53,723 | 48.2 K to 53.7 K (+11.36 %) |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | A | 27.15 | 8,208 | 222,847 | 8,208 | |
Feb 27 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 4,420 | 0 | 48,243 | 43.8 K to 48.2 K (+10.09 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 28.50 | 429 | 12,227 | 43,823 | 44.3 K to 43.8 K (-0.97 %) |
Feb 24 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 28.50 | 637 | 18,155 | 44,252 | 44.9 K to 44.3 K (-1.42 %) |
Feb 20 2015 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 27.22 | 581 | 15,815 | 44,889 | 45.5 K to 44.9 K (-1.28 %) |
Dec 30 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Gift | G | 0.00 | 300 | 0 | 45,470 | 45.8 K to 45.5 K (-0.66 %) |
Jul 29 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | M | 4.31 | 12,759 | 54,991 | 0 | |
Jul 29 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | M | 4.31 | 12,759 | 54,991 | 45,770 | 33 K to 45.8 K (+38.65 %) |
Feb 28 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 21.43 | 2,021 | 43,310 | 33,011 | 35 K to 33 K (-5.77 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | M | 4.23 | 20,000 | 84,600 | 0 | |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 21.75 | 441 | 9,592 | 35,032 | 35.5 K to 35 K (-1.24 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 21.84 | 590 | 12,886 | 35,473 | 36.1 K to 35.5 K (-1.64 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 21.78 | 3,894 | 84,811 | 36,063 | 40 K to 36.1 K (-9.75 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | M | 4.23 | 20,000 | 84,600 | 39,957 | 20 K to 40 K (+100.22 %) |
Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 22.05 | 4,638 | 102,268 | 19,957 | 24.6 K to 20 K (-18.86 %) |
Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | A | 20.16 | 10,638 | 214,462 | 10,638 | |
Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 5,952 | 0 | 24,595 | 18.6 K to 24.6 K (+31.93 %) |
Dec 26 2013 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Gift | G | 0.00 | 1,400 | 0 | 18,643 | 20 K to 18.6 K (-6.98 %) |
Dec 26 2013 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 16.85 | 506 | 8,526 | 20,043 | 20.5 K to 20 K (-2.46 %) |
Feb 25 2013 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | A | 16.45 | 12,067 | 198,502 | 12,067 | |
Feb 25 2013 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 6,991 | 0 | 20,549 | 13.6 K to 20.5 K (+51.56 %) |
Dec 31 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Gift | G | 0.00 | 1,300 | 0 | 13,558 | 14.9 K to 13.6 K (-8.75 %) |
Dec 13 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Gift | G | 0.00 | 3,000 | 0 | 14,858 | 17.9 K to 14.9 K (-16.80 %) |
Nov 16 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | M | 4.23 | 17,338 | 73,340 | 0 | |
Nov 16 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | M | 4.23 | 1,800 | 7,614 | 17,338 | |
Nov 16 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 14.38 | 9,000 | 129,420 | 22,753 | 31.8 K to 22.8 K (-28.34 %) |
Nov 16 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | M | 4.23 | 17,338 | 73,340 | 31,753 | 14.4 K to 31.8 K (+120.28 %) |
Nov 16 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 14.56 | 1,000 | 14,560 | 14,415 | 15.4 K to 14.4 K (-6.49 %) |
Nov 16 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | M | 4.23 | 1,800 | 7,614 | 15,415 | 13.6 K to 15.4 K (+13.22 %) |
Nov 21 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | M | 4.23 | 4,243 | 17,948 | 19,999 | |
Nov 21 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | M | 4.23 | 4,243 | 17,948 | 17,858 | 13.6 K to 17.9 K (+31.16 %) |
Nov 20 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 14.64 | 6,867 | 100,533 | 13,615 | 20.5 K to 13.6 K (-33.53 %) |
Nov 20 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 14.68 | 2,271 | 33,338 | 20,482 | 22.8 K to 20.5 K (-9.98 %) |
May 29 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 15.86 | 7,000 | 111,020 | 13,615 | 20.6 K to 13.6 K (-33.96 %) |
May 18 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | P | 15.69 | 2,000 | 31,380 | 20,615 | 18.6 K to 20.6 K (+10.74 %) |
Feb 24 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | A | 22.04 | 9,330 | 205,633 | 9,330 | |
Feb 24 2012 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 5,220 | 0 | 18,615 | 13.4 K to 18.6 K (+38.97 %) |
Apr 20 2011 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | P | 16.00 | 1,000 | 16,000 | 1,000 | 0 to 1,000 |
Page: 1